Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Christensen, Merete StubkjaerHeyman, Mats
Möttönen, Merja
Zeller, Bernward
Jonmundsson, Gudmundur
Hasle, Henrik
Issue Date
2005-10-01
Metadata
Show full item recordCitation
Br. J. Haematol. 2005, 131(1):50-8Abstract
Despite continuously more successful treatment of childhood acute lymphoblastic leukaemia (ALL), 2-5% of children still die of other causes than relapse. The Nordic Society of Paediatric Haematology and Oncology-ALL92 protocol included 1652 patients < or =15 years of age with precursor B- and T-cell ALL diagnosed between 1992 and 2001. Induction deaths and deaths in first complete remission (CR1) were included in the study. A total of 56 deaths (3%) were identified: 19 died during induction (1%) and 37 in CR1 (2%). Infection was the major cause of death in 38 cases. Five patients died of early death before initiation of cytotoxic therapy. Five patients died because of toxicity of inner organs and one of accidental procedure failures. Seven patients died of complications following allogenic haematopoietic stem cell transplantation (HSCT) in CR1. Girls were at higher risk of treatment-related death (TRD) [relative risk (RR) = 2.2; 95% confidence interval (CI(95%)): 1.2-4.0, P < 0.01], mostly because of infections. Risk of TRD was also higher in children with Down syndrome (RR = 4.5; CI(95%): 2.0-10.2, P < 0.00). In conclusion, 3% of children with ALL died of TRD, with bacterial infections as the most common cause of death. Girls and Down syndrome patients had a higher risk of TRD. Infections still remain a major challenge in childhood ALL.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldae974a485f413a2113503eed53cd6c53
10.1111/j.1365-2141.2005.05736.x
Scopus Count
Collections
Related articles
- Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia.
- Authors: Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO).
- Issue date: 2011 Mar
- Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data.
- Authors: Saarinen-Pihkala UM, Heilmann C, Winiarski J, Glomstein A, Abrahamsson J, Arvidson J, Békássy AN, Forestier E, Jonmundsson G, Schroeder H, Vettenranta K, Wesenberg F, Gustafsson G
- Issue date: 2006 Dec 20
- Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
- Authors: Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO).
- Issue date: 2010 Dec
- Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.
- Authors: Lund B, Åsberg A, Heyman M, Kanerva J, Harila-Saari A, Hasle H, Söderhäll S, Jónsson ÓG, Lydersen S, Schmiegelow K, Nordic Society of Paediatric Haematology and Oncology.
- Issue date: 2011 Apr
- Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?
- Authors: Te Poele EM, de Bont ES, Marike Boezen H, Revesz T, Bökkerink JP, Beishuizen A, Nijhuis IJ, Oude Nijhuis CS, Veerman AJ, Kamps WA
- Issue date: 2007 Nov